Aeglea BioTherapeutics logo

Aeglea BioTherapeutics Employee Directory

Biotechnology ResearchTexas, United States2-10 Employees

Aeglea BioTherapeutics is a biotechnology research company based in Austin, Texas. It has shifted its disease focus to inflammatory bowel disease following the acquisition of Spyre Therapeutics. Spyre Therapeutics brings capabilities in antibody engineering, rational therapeutic combinations, and precision immunology intended to enhance the effectiveness, safety, and convenience of IBD treatments. The move aligns Aeglea with Spyre’s program to pursue therapies for this disease area.

The company targets patients with inflammatory bowel disease and the clinicians who treat them by pursuing more effective therapeutic options. In 2023, the organization announced a name change to Spyre Therapeutics and expanded its leadership to develop next-generation therapeutic combinations for inflammatory bowel disease.

Find Aeglea BioTherapeutics employees' phone numbers or email addresses

Aeglea BioTherapeutics Global Highlights

Location
Employees

North America
34

Minus sign iconPlus sign icon
  • United States Of America
    34

Europe
3

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • Netherlands
    1

Aeglea BioTherapeutics's Leadership

  • Chief Operating Officer at Aeglea BioTherapeutics
    C. T.
    Chief Operating Officer
  • Vice President Human Resources at Aeglea BioTherapeutics
    T. D.
    Vice President Human Resources
  • Vice President, Clinical Operations And Data Management at Aeglea BioTherapeutics
    C. S.
    Vice President, Clinical Operations And Data Management
  • Senior Director Clinical Science, Clinical Development. Rare Genetic Disease at Aeglea BioTherapeutics
    G. B.
    Senior Director Clinical Science, Clinical Development. Rare Genetic Disease
  • Director Of Pharmacovigilance at Aeglea BioTherapeutics
    A. M. C.
    Director Of Pharmacovigilance
  • Senior Director, Portfolio And Project Management Office at Aeglea BioTherapeutics
    M. R.
    Senior Director, Portfolio And Project Management Office
  • Senior Director Of Clinical Operations at Aeglea BioTherapeutics
    S. B.
    Senior Director Of Clinical Operations
  • Executive Director Translational Science at Aeglea BioTherapeutics
    S. A.
    Executive Director Translational Science

Aeglea BioTherapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Operations
  • Manufacturing
  • Program & Project Management
  • Research
  • Engineering
  • Other
  • Analytics
  • Consultant
  • Legal
  • Business
  • Biotechnology

Contact profiles from Aeglea BioTherapeutics

Name
Title
Contact
Location
Last Update
  • Chief Operating Officer at Aeglea BioTherapeutics
    C. T.
    Chief Operating Officer
    Oct 23, 2023
  • Vice President, Clinical Operations And Data Management at Aeglea BioTherapeutics
    C. S.
    Vice President, Clinical Operations And Data Management
    Aug 26, 2026
  • Vice President Human Resources at Aeglea BioTherapeutics
    T. D.
    Vice President Human Resources
    Oct 22, 2024
  • Senior Director Clinical Science, Clinical Development. Rare Genetic Disease at Aeglea BioTherapeutics
    G. B.
    Senior Director Clinical Science, Clinical Development. Rare Genetic Disease
    United Kingdom, England
    Aug 31, 2026
  • Director Of Pharmacovigilance at Aeglea BioTherapeutics
    A. M. C.
    Director Of Pharmacovigilance
    Oct 18, 2024
  • Senior Director, Portfolio And Project Management Office at Aeglea BioTherapeutics
    M. R.
    Senior Director, Portfolio And Project Management Office
    Oct 24, 2024
  • Senior Director Of Clinical Operations at Aeglea BioTherapeutics
    S. B.
    Senior Director Of Clinical Operations
    Jul 08, 2024
  • Executive Director Translational Science at Aeglea BioTherapeutics
    S. A.
    Executive Director Translational Science
    Oct 23, 2024
  • Associate Manager Of Biology Research at Aeglea BioTherapeutics
    M. W.
    Associate Manager Of Biology Research
    Oct 23, 2024
  • It Consultant at Aeglea BioTherapeutics
    B. M.
    It Consultant
    Oct 17, 2024

Frequently Asked Questions

What is Aeglea BioTherapeutics known for?

Minus sign iconPlus sign icon
Aeglea BioTherapeutics was founded in 2013 and operates in the Biotechnology Research industry. You can contact Aeglea BioTherapeutics's main corporate office by phone at . Explore Aeglea BioTherapeutics's company overview page for more information.

What is Aeglea BioTherapeutics's most common email format?

Minus sign iconPlus sign icon
Aeglea BioTherapeutics employees' email format typically follows the pattern of FLast@aegleabio.com. Trying to find reliable and up-to-date employee contact data? Find more Aeglea BioTherapeutics email formats with LeadIQ.

How many employees does Aeglea BioTherapeutics have currently?

Minus sign iconPlus sign icon
Aeglea BioTherapeutics has approximately 10 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Aeglea BioTherapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Aeglea BioTherapeutics's key employees include:

  • Chief Operating Officer: C. T.
  • Vice President Human Resources: T. D.
  • Vice President, Clinical Operations And Data Management: C. S.
  • Senior Director Clinical Science, Clinical Development. Rare Genetic Disease: G. B.
  • Director Of Pharmacovigilance: A. M. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.